Compare ARK Genomic Revolution ETF (ARKG) vs Under Armour Inc Class A (UA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Under Armour Inc Class A — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Under Armour Inc Class A trades at $6.54 (market cap $2.86B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| ARKG | UA | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $7.88 |
52-Week Low | $23.09 | $3.96 |
Market Cap | — | $2.86B |
Enterprise Value | — | $4.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Under Armour (UA) trades at $6.61, up 2.48% with a bullish technical signal from moving averages. The company reported mixed Q1 2026 results with an EPS miss but maintains a 40.3% analyst buy rating. Recent financials show revenue of $5.16B for 2025 with negative net income of -$201.27M, though gross margins remain healthy at 45.48%. The Dodge collaboration and institutional buying by Prem Watsa provide positive catalysts amid ongoing business restructuring.
The outlook remains challenging with declining revenue projections and negative profitability metrics, but current valuation at 0.57 P/S offers potential for turnaround investors. Key risks include sustained revenue declines, competitive pressures, and negative cash flow trends. Institutional sentiment appears cautiously optimistic despite fundamental headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
